Add BrightSurf on Google Email

Researchers create nanoparticle-vaccine combination to target melanoma

07.20.22 | University of Iowa
Rigol DP832 Triple-Output Bench Power Supply

Rigol DP832 Triple-Output Bench Power Supply powers sensors, microcontrollers, and test circuits with programmable rails and stable outputs.
Melanoma killers
Pharmaceutical scientists at the University of Iowa have found that a charged nanoparticle-vaccine combination eliminated tumors or extended life span in mice with melanoma tumors. The image shows a melanoma tumor, with blood and lymphatic vessels. The magnified portion shows how the charged nanoparticles stimulate immune cells to locate and fight the tumor. Credit: Aliasger Salem lab, University of Iowa

Science Advances

Experimental study

Animals

Cationic nanoparticles enhance T cell tumor infiltration and antitumor immune responses to a melanoma vaccine

20-Jul-2022

There is no conflict of interest in the research.

Keywords

Melanoma

Article Information

Journal
Science Advances
Method of Research
Experimental study
Subject of Research
Animals
Article Publication Date
2022-07-20
Article Title
Cationic nanoparticles enhance T cell tumor infiltration and antitumor immune responses to a melanoma vaccine
COI Statement
There is no conflict of interest in the research.

Contact Information

Richard Lewis
University of Iowa
richard-c-lewis@uiowa.edu

How to Cite This Article

APA:
University of Iowa. (2022, July 20). Researchers create nanoparticle-vaccine combination to target melanoma. Brightsurf News. https://www.brightsurf.com/news/1ZZVN4R1/researchers-create-nanoparticle-vaccine-combination-to-target-melanoma.html
MLA:
"Researchers create nanoparticle-vaccine combination to target melanoma." Brightsurf News, Jul. 20 2022, https://www.brightsurf.com/news/1ZZVN4R1/researchers-create-nanoparticle-vaccine-combination-to-target-melanoma.html.